CLINICAL_TRIALS
trial_result
· 2023-10-04
Clinical Trial Update: Fenfluramine in CDKL5 Deficiency Disorder (CDD) [Phase 2]
Summary
Phase 2 trial update for fenfluramine in CDKL5 deficiency disorder has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: CDD | Phase 2 | Status: COMPLETED | Results posted: 2023-10-04